The Effect of Telemedicine in Glycemic Control in Adult Patients with Diabetes during the COVID-19 Era-A Systematic Review.

The Effect of Telemedicine in Glycemic Control in Adult Patients with Diabetes during the COVID-19 Era-A Systematic Review.
复制标题

DOI:
10.3390/jcm12175673
复制
发表时间:
2023-08-31
影响因子:
3.9
通讯作者:
--
中科院分区:
医学2区
文献类型:
--
作者:

文献摘要

参考文献

相似文献

远程医疗可以成为管理慢性病的有效工具。COVID-19大流行对传统糖尿病护理造成的破坏引发了全球对远程医疗的兴趣。通过这篇手稿,我们评估了远程医疗在大流行期间用于糖尿病管理的应用及其对血糖控制的影响,重点关注回顾性和前瞻性研究,其中包括成年、非妊娠糖尿病患者。根据提供的可用信息,我们评估了HbA 1c、范围内时间(TIR)、血糖管理指标(GMI)、平均血糖值、低血糖发作、低于范围的时间(TBR)或因低血糖/DKA住院治疗是否有所改善。这篇综述文章强调了远程医疗在全球紧急状态期间的好处,这改变了医疗保健服务的标准。在本次审查报告的研究中,远程医疗被证明是管理糖尿病的有效工具,说明其有可能成为新的护理标准。尽管这些改善可能会受到大流行期间存在的潜在外来因素的干扰,但远程医疗已被证明对血糖控制有积极影响。总体而言,这篇文章强调了远程医疗在全球紧急状态期间对血糖控制的好处,这改变了护理标准。随着COVID-19限制的取消以及重返办公室,本文强调了研究与传统护理标准相比如何最好地利用远程医疗进行糖尿病管理的必要性。
Telemedicine can be an effective tool for managing chronic diseases. The disruption in traditional diabetes care resulting from the COVID-19 pandemic led to global interest in telemedicine. With this manuscript, we evaluated the use of telemedicine for the management of diabetes during the pandemic and its impact on glycemic control, focusing on retrospective and prospective studies which included adult, non-pregnant patients with diabetes. We evaluated whether there was an improvement in HbA1c, time in range (TIR), glucose management indicator (GMI), mean glucose values, hypoglycemic episodes, time below range (TBR), or hospitalizations for hypoglycemia/DKA, depending on the available information provided. This review article highlights the benefits of telemedicine during the global state of emergency, which altered the standard of healthcare delivery. Across the studies reported in this review, telemedicine was shown to be an effective tool for the management of diabetes, illustrating its potential to be the new standard of care. Although these improvements may be confounded by potential extraneous factors present during the pandemic, telemedicine was shown to positively impact glycemic control. Overall, this article highlights the benefits of telemedicine on glycemic control during the global state of emergency, which altered the standard of care. With the rollback of COVID-19 restrictions, and a return to the office, this article emphasizes the necessity to study how telemedicine can be best utilized for diabetes management when compared to the traditional standard of care.
DOI: 10.2196/24552
发表时间: 2021-04-06
影响因子: 7.4
作者:
Parise M;Tartaglione L;Cutruzzolà A;Maiorino MI;Esposito K;Pitocco D;Gnasso A;Irace C
通讯作者: Irace C
DOI: 10.1111/jdi.13826
发表时间: 2022-09
影响因子: 3.2
作者:
Onishi, Yukiko;Ichihashi, Rieko;Yoshida, Yoko;Tahara, Tazu;Kikuchi, Takako;Kobori, Toshiko;Kubota, Tetsuya;Iwamoto, Masahiko;Hamano, Shoko;Kasuga, Masato
通讯作者: Kasuga, Masato
DOI: 10.1177/20406223211042542
发表时间: 2021
影响因子: 3.5
作者:
Faleh AlMutairi M;Tourkmani AM;Alrasheedy AA;ALHarbi TJ;Bin Rsheed AM;ALjehani M;AlRuthia Y
通讯作者: AlRuthia Y
DOI: 10.2337/dc17-1669
发表时间: 2018-01
期刊: Diabetes care
影响因子: 16.2
作者:
Lee AK;Warren B;Lee CJ;McEvoy JW;Matsushita K;Huang ES;Sharrett AR;Coresh J;Selvin E
通讯作者: Selvin E
DOI: 10.1111/dme.12282
发表时间: 2013-12-01
期刊: DIABETIC MEDICINE
影响因子: 3.5
作者:
Holman, N.;Hillson, R.;Young, R. J.
通讯作者: Young, R. J.